RKT Editorial Team in collaboration with
Quality Assurance Management
Plastic Injection Molding under Cleanroom Conditions

This article outlines the challenges that have to be mastered during injection molding and the subsequent assembly and packaging in volume production, and which processes and control mechanisms are required.
You can find the subtopics of this article in condensed form here: cleanroom production to ISO 8 and ISO 7, maintaining the cleanroom outside production hours, and conduct within the cleanroom.
At RKT, we specialize in manufacturing demanding medical components under cleanroom conditions using the plastic injection molding process. The groundwork for this was laid in 2006 with the realization of production for the first medical components and the associated establishment of an ISO 8 cleanroom at the Roding site. Initially, this was a customer requirement for manufacturing plastic parts for insulin pens.
New Production Conditions Under ISO 7
The follow-up projects became more complex, and so the first ISO 7 / GMP Class C cleanroom was implemented for the production of needle protection systems for diabetes therapy, which also required official qualification to ISO 14644-1. In an ISO 7 cleanroom, 352,000 particles per cubic meter of air with a size of ≤ 0.5 µm are permitted. This brought new challenges and a tightening of the existing conditions. The task was to find a way to transfer parts manufactured in an injection molding machine into a cleanroom without introducing contamination. Moreover, the injection molding machines themselves were not particularly cleanroom-compatible at the time. These were predominantly hydraulic machines that ran on oil, among other things. This meant potential contamination. By now, there are special cleanroom machines tailored to the respective needs. These are electric machines that are water-cooled and therefore require no fans, which would cause turbulence in the room.
The solution for the injection molding machines of that era was to position the machine outside and have it produce into the cleanroom using an appropriate protective concept – which remains common practice even with modern machines, depending on the cleanroom class. All maintenance and all particle-generating activities could and can thus be conveniently carried out outside the cleanroom. Technicians and tools therefore do not need to be brought in through the airlock. The injection molding machine is docked to the cleanroom. On the cleanroom side, a robot is positioned to remove the parts from the mold and deposit them in the cleanroom. The critical point is the connection or opening between the two areas; here, care must be taken to ensure that no contamination enters the cleanroom, which is guaranteed by a laminar flow box above the respective areas. This generates a laminar flow—that is, the air streaming downward flows in parallel streamlines. In this way, particles are captured by the parallel airflow and carried outward.
A further reason for placing the injection molding machines outside the cleanroom is the turbulence that can arise from the relatively fast movements of the mold inside the machine during part production. As a general rule, fast movements in the cleanroom – whether by humans or machines -must be avoided so as not to stir up particles that can then settle back onto surfaces and, ultimately, the product.
The more potentially critical processes that can take place outside the cleanroom, and the fewer people or items that need to be brought in through the airlock, the better. In this respect, a key consideration during planning was to make cleanroom operation as maintenance-friendly and as independent of personnel as possible. The main source of contamination in a cleanroom is always the human being. The more activities a person has to perform in the cleanroom, the greater the risk of contamination. In the case of the needle protection systems, such autonomy of the system was achieved that only once every two days does a person in appropriate cleanroom clothing enter the room and pack the product in double bags.
The procedure of the early years proved successful and was retained – that is, in the follow-up projects and the two additional ISO 7 / GMP Class C cleanrooms established due to increasing order volumes, the injection molding machine likewise remained outside the actual cleanroom area. Thanks to largely unmanned production and the maintenance work performed outside, we achieve very good values in the relevant areas (see the charts below under “Targeted Monitoring”).
A New Challenge: Freedom from Analytes
A new challenge arose with the inquiry for analyte-free production of PCR test cartridges. The PCR test enables immediate determination of results for the detection of pathogens – including the SARS-CoV-2 pathogen – at laboratory quality in less than an hour. With the microfluidic cartridges, extremely fine structures are created during injection molding. These cartridges are filled with reagents that respond specifically to, for example, SARS-CoV-2 and enable a fully automated analysis directly at the point of care.
In production, it is not only a matter of complying with certain particle parameters, but in particular of preventing the introduction of foreign DNA or RNA. In principle, the requirements for the cleanroom technology are the same as when the focus is on particles. However, for the air to achieve the required cleanliness and freedom from analytes, certain filters must be installed that regularly filter both the incoming air and the air inside. Technically, it is entirely possible to filter out microorganisms and viruses; nevertheless, it is problematic if the germs have already found their way into the cleanroom. As a rule, this happens via human skin and is difficult to prevent. To prevent the unwanted target nucleic acid sequence of the pathogens – which is to be detected later with the test cartridges – from entering the cleanroom, however, we have defined strict measures for the cleanroom staff: every employee who comes into contact with the product is tested for the target germ in advance, with their consent – in the case of the SARS-CoV-2 pathogen, by means of a daily rapid antigen test – to ensure that no introduction of this target RNA can occur here. Should an employee be carrying the pathogen, they receive a ban on entering this production cell.
Planning a Cleanroom
Everything depends on the product when it comes to planning and designing a cleanroom. The customer generally defines the product risk and the hygiene requirements. Many customers can provide very precise specifications regarding classification and other requirements, while some start-up companies without experience in the industrial volume production of medical components need expertise and consulting from the plastics specialist. Once these basic requirements have been clarified, the available production area in the cleanroom can be planned. There may be especially sensitive process steps, as in the case of the PCR tests, where freedom from analytes was the highest requirement. In this case, a sterile bench was provided within the cleanroom that works with UV light and can kill germs at certain process steps by means of the UV light, thus representing yet another safety level. In this way, individual solutions can be found and tailored to the respective product. Such a workbench solution within an existing ISO 7 cleanroom also enables a higher cleanroom classification to ISO 6 for the respective manufacturing steps.
For more complex manufacturing operations involving several processes such as injection molding and subsequent assembly, it is advantageous if all work can be carried out within one cleanroom without passing items in and out through airlocks. In the production of a cartridge for a cell therapy for leukemia patients, these various process steps can—in terms of space capacity—be mapped within a single cleanroom, since the product is produced on demand and not held in stock.
Other products, such as the PCR cartridge for the detection of SARS-CoV-2, are produced for stock due to the varying call-off quantities – significantly fewer in summer than in fall/winter. But since clean storage space within the cleanroom would be far too costly – the upkeep conditions of a cleanroom mean a great deal of energy, electricity, and effort – the pre-produced plastic cartridges, which are only filled with their biochemical reagents and made ready for use later, must first be packaged and passed out through the airlock to be stored outside. For this purpose, the parts are double-bagged and stored in plastic containers in high-bay racking. For further processing in the next cleanroom, the outer bag is removed in the material airlock as part of the defined airlock-in procedure, and the inner bag with the component can be brought into the cleanroom, where it is opened and processed further. The cleanroom is therefore always planned and used exclusively as a production area, never as a storage area.
Special Process Steps: Lyophilizates
In addition to freedom from particles and analytes, the manufacture of medical products such as the PCR tests involves further requirements that must be regulated in the cleanroom: humidity and temperature. Lyophilizates – freeze-dried substances that are later intended to react with the sample material of the person being tested – are introduced into the microfine channels of the test cartridges. Lyophilizates are extremely fragile and hygroscopic. If the humidity exceeds 50 percent, they draw in water and dissolve immediately. The humidity in the cleanroom must therefore not exceed 50 percent, and a temperature of 25 °C must not be exceeded. In addition, the respective container may be open for a maximum of twelve hours. Everything is monitored automatically, and the times are tracked. The product is opened, the barcode is scanned, and should the twelve hours be exceeded – for example, due to a malfunction in the system – production is automatically halted and these lyophilizates cannot be processed further. With such humidity requirements, occupational safety also comes into play. Since the PCR tests involve less automation and employees are involved in the production process, the humidity must not fall below certain limits, and the relevant occupational safety guidelines must be observed.
Balancing the optimal humidity is not trivial. Increasing the moisture in the room is less problematic than dehumidification. The dehumidification process is complex, since the air first has to be heated, then cooled back down by a chiller so that condensation can be separated out. In weather-related high ambient humidity, the drying systems run at full capacity during production.

Special Process Steps: Blister Packaging with Tyvek Film
All measures taken in the cleanroom serve to protect the product being manufactured from contamination by particles or germs. For the cartridge used as part of leukemia therapy, this aspect is particularly sensitive, since in the therapeutic procedure, genetically modified cell material is introduced into the patient’s body in a flow-through process, which is then intended to recognize and eliminate cancer cells. Contamination here could have serious consequences, such as additional, life-threatening infections for these already immunocompromised individuals. In this respect, strict compliance with all parameters is essential for this product.
What matters is the sterilization of the products, which, however, only takes place downstream at the customer’s site. To enable this step to be carried out free of contamination after the products have been passed out of the cleanroom, the cartridge is blister-packed after assembly in a plastic container with a so-called Tyvek film. This film is impermeable to particles and germs, but a sterilization gas such as ethylene oxide can penetrate and exit again. The cartridge can therefore be sterilized at the customer’s site in its primary packaging without difficulty.
The Human Success Factor
Overall, cleanroom production depends on a high level of commitment from employees. When employees identify with the cleanroom requirements, this is also reflected in inconspicuous monitoring results. A hygiene manager regularly checks compliance with the cleanroom rules on site and confirms a high degree of discipline among colleagues. The requirements are high: from day one, training sessions are part of the daily routine for new employees. Even the correct donning of protective clothing—without already contaminating the outsides of the suits in the process—takes practice. The slow, even movements that work in the cleanroom requires must also be trained. The removal of personal items (such as jewelry) and the observance of a certain waiting period after smoking, to avoid nicotine particles, are likewise among the obligatory behaviors in the cleanroom.
Targeted Monitoring and Annual Qualification
Depending on the cleanroom class, monitoring tracks either particles or germs. In an ISO 7 cleanroom, the focus is on avoiding particles and dirt. With GMP Class C, the aim is additionally to limit the microbial load. In principle, neither the cleanroom and ventilation technology nor the gowning concept differ for the two classes. The measurements that have to be carried out, however, differ fundamentally. Our ISO 7 cleanrooms are tested for both particles and germs, so that different components can be manufactured here according to requirements. For ISO 7, airborne particle measurements are decisive. For this purpose, the particle counter is placed in the cleanroom, draws in the air, and evaluates how many particles per cubic meter are contained in the air. Depending on the size of the cleanroom, several measurement points within the cleanroom must be evaluated.
Assessing the microbial load for GMP Class C is somewhat more involved. For contact plate samples, certain sampling locations in the cleanroom are defined using a risk-based approach, at which agar plates are applied as a culture medium. These are incubated in the laboratory for a few days to check whether the colony-forming units (CFUs) remain within the defined range.



In addition to the routine monitoring, ISO Class 7 requires an annual qualification carried out by an external company. Among other things, every single filter is inspected and a filter integrity test is performed. In this test, certain air particles are applied to the filter from outside, and a check is made of how many particles actually arrive in the cleanroom. The filter must filter out 99.998 percent of all particles. Even with a deterioration of 0.01 percentage points, the filter in question must be replaced. As a rule, the filters have a service life of about five years, depending on where they are used.
Documentation
In addition to monitoring, documentation is also of great importance. All processes are tracked and monitored via CAQ (computer-aided quality) systems. At the conclusion of production, a certificate is delivered to the customer, for both the PCR tests and the cell therapy cartridge. This includes a checklist: Are all measured values in order, are the dimensions of the component correct, were the production conditions met, batch traceability? All of these aspects are checked once more before the article is shipped to the customer. Only with the signature of the certificate officer is the component actually released.
Outlook
Owing to their favorable properties—such as biocompatibility, chemical resistance, and sterilizability—plastics remain a central material for medical technology components. With injection molding, these can be manufactured cost-effectively in large quantities. The greatest challenge here lies in the stringent hygiene measures that medical products require, depending on the application.
Especially with new product ideas, what often matters is transferring them from their development status into industrial volume production—and that under professional cleanroom conditions. For each product, the individually suitable processes and control mechanisms are set up to enable low-contamination production even at high volumes. Microfluidic test cartridges in particular, as so-called “lab-on-a-chip” devices, are increasingly in demand. These mini-laboratories can be adapted to detect a wide variety of pathogens and are already undergoing further development at our company.



